Transcript 第58回関西胸部外科学会学術集会 The 58th Annual Meeting of

第5８回関西胸部外科学会学術集会
The 58th Annual Meeting of Kansai Thoracic Surgical Association
The Japanese Association for
Thoracic Surgery
COI Disclosure
The author has no conflict of
interest to disclose with respect
to this presentation.
Presenting author: ●● ●●
第5８回関西胸部外科学会学術集会
The 58th Annual Meeting of Kansai Thoracic Surgical Association
The Japanese Association for
Thoracic Surgery
COI Disclosure
Research funding has been
received from ○○○○.
Presenting author: ●● ●●
第5８回関西胸部外科学会学術集会
The 58th Annual Meeting of Kansai Thoracic Surgical Association
The Japanese Association for
Thoracic Surgery
COI Disclosure
Lecture fees have been
received from ○○○○.
Presenting author: ●● ●●
第5８回関西胸部外科学会学術集会
The 58th Annual Meeting of Kansai Thoracic Surgical Association
The Japanese Association for
Thoracic Surgery
COI Disclosure
Research funding as an advisor
has been received from
○○○○.
Presenting author: ●● ●●
第5８回関西胸部外科学会学術集会
The 58th Annual Meeting of Kansai Thoracic Surgical Association
The Japanese Association for Thoracic Surgery
COI Disclosure
Presenting author: ●● ●●
Amount
Applicable
Exective/
advisor
＞1,000,000 yen
No
Stocks
＞1,000,000 yen profit
/ shareholding ＞5%
No
Patent royalties
＞1,000,000 yen
No
Lecture fees, etc.
＞1,000,000 yen
No
Manuscript fees,
etc.
＞1,000,000 yen
No
Research expenses
＞2,000,000 yen
Yes
Name of Company Concerned
Xxxx Pharmaceuticals